{"id":4959,"date":"2025-11-01T15:17:45","date_gmt":"2025-11-01T12:17:45","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4959"},"modified":"2025-11-03T14:12:47","modified_gmt":"2025-11-03T11:12:47","slug":"north-star-ambulatory-assessment-nsaa-in-duchenne-dmd","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/north-star-ambulatory-assessment-nsaa-in-duchenne-dmd\/","title":{"rendered":"Duchenne Musk\u00fcler Distrofisi'nde (DMD) Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirmesi (NSAA)"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>North Star Ambulatuvar De\u011ferlendirmesi (NSAA), Duchenne kas distrofisi (DMD) olan ayakta tedavi g\u00f6ren erkek \u00e7ocuklarda motor performans\u0131 de\u011ferlendirmek i\u00e7in tasarlanm\u0131\u015f, klinisyen taraf\u0131ndan uygulanan standart bir ara\u00e7t\u0131r.<\/strong> North Star Klinik N\u00f6rom\u00fcsk\u00fcler Hastal\u0131klar A\u011f\u0131 taraf\u0131ndan geli\u015ftirilen bu y\u00f6ntem, hem klinik uygulamada hem de ara\u015ft\u0131rma ortamlar\u0131nda hastal\u0131\u011f\u0131n ilerlemesini izlemek ve tedavi sonu\u00e7lar\u0131n\u0131 de\u011ferlendirmek i\u00e7in g\u00fcvenilir bir yol sa\u011flar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi, DMD genindeki mutasyonlardan kaynaklanan ilerleyici bir n\u00f6rom\u00fcsk\u00fcler hastal\u0131kt\u0131r ve kas stabilitesi i\u00e7in kritik bir protein olan distrofin eksikli\u011fine yol a\u00e7ar. Zamanla bu durum kas g\u00fc\u00e7s\u00fczl\u00fc\u011f\u00fcne, y\u00fcr\u00fcme kayb\u0131na ve fonksiyonel gerilemeye neden olur. <strong>Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirmesi (NSAA), \u00f6l\u00e7\u00fclebilir bir dizi motor g\u00f6revi arac\u0131l\u0131\u011f\u0131yla bu ilerlemenin niceliksel olarak belirlenmesine yard\u0131mc\u0131 olur.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#purpose-and-importance-of-the-nsaa-in-dmd\">DMD&#039;de NSAA&#039;n\u0131n Amac\u0131 ve \u00d6nemi<\/a><\/li><li><a href=\"#structure-and-scoring-of-the-nsaa\">NSAA&#039;n\u0131n Yap\u0131s\u0131 ve Puanlamas\u0131<\/a><\/li><li><a href=\"#nsaa-assessed-skills\">NSAA Taraf\u0131ndan De\u011ferlendirilen Beceriler<\/a><\/li><li><a href=\"#interpreting-nsaa-scores\">NSAA Puanlar\u0131n\u0131n Yorumlanmas\u0131<\/a><\/li><li><a href=\"#use-of-the-nsaa-in-clinical-trials\">NSAA&#039;n\u0131n Klinik Ara\u015ft\u0131rmalarda Kullan\u0131m\u0131<\/a><\/li><li><a href=\"#limitations-of-the-nsaa\">NSAA&#039;n\u0131n s\u0131n\u0131rlamalar\u0131<\/a><\/li><li><a href=\"#most-common-question-about-north-star-ambulatory-assessment-nsaa\">North Star Ambulatuvar De\u011ferlendirmesi (NSAA): Sorular ve Cevaplar<\/a><ul><li><a href=\"#faq-question-1761824999344\">Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirmesi (NSAA) nedir?<\/a><\/li><li><a href=\"#faq-question-1761825035673\">Duchenne Musk\u00fcler Distrofi&#039;de NSAA neden kullan\u0131l\u0131r?<\/a><\/li><li><a href=\"#faq-question-1761825143662\">NSAA testini kimler yapt\u0131rabilir?<\/a><\/li><li><a href=\"#faq-question-1761825159756\">NSAA nas\u0131l puanlan\u0131yor?<\/a><\/li><li><a href=\"#faq-question-1761825213163\">NSAA&#039;n\u0131n tamamlanmas\u0131 ne kadar zaman al\u0131r?<\/a><\/li><li><a href=\"#faq-question-1761825239921\">NSAA tam olarak neyi \u00f6l\u00e7\u00fcyor?<\/a><\/li><li><a href=\"#faq-question-1761825277811\">NSAA hangi ya\u015flarda kullan\u0131labilir?<\/a><\/li><li><a href=\"#faq-question-1761825294335\">NSAA ne s\u0131kl\u0131kla yap\u0131lmal\u0131d\u0131r?<\/a><\/li><li><a href=\"#faq-question-1761825309981\">Duchenne Musk\u00fcler Distrofisi&#039;nde klinik \u00e7al\u0131\u015fmalarda NSAA nas\u0131l kullan\u0131l\u0131r?<\/a><\/li><li><a href=\"#faq-question-1761825328456\">NSAA&#039;n\u0131n s\u0131n\u0131rlamalar\u0131 nelerdir?<\/a><\/li><li><a href=\"#faq-question-1761825354752\">DMD&#039;li bir \u00e7ocuk y\u00fcr\u00fcyemez hale geldi\u011finde ne olur?<\/a><\/li><li><a href=\"#faq-question-1761825371612\">NSAA DMD&#039;de y\u00fcr\u00fcme kayb\u0131n\u0131 \u00f6ng\u00f6rebilir mi?<\/a><\/li><li><a href=\"#faq-question-1761825393528\">NSAA g\u00fcvenilir ve ge\u00e7erli mi?<\/a><\/li><li><a href=\"#faq-question-1761825415116\">Aileler \u00e7ocuklar\u0131n\u0131 NSAA testine nas\u0131l haz\u0131rlayabilirler?<\/a><\/li><li><a href=\"#faq-question-1761825442589\">NSAA formu veya puanlama tablosu nerede bulunabilir?<\/a><\/li><\/ul><\/li><li><a href=\"#conclusion\">Sonu\u00e7<\/a><ul><li><a href=\"#key-takeaways\">\u00d6nemli \u00c7\u0131kar\u0131mlar<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"purpose-and-importance-of-the-nsaa-in-dmd\"><strong>DMD&#039;de NSAA&#039;n\u0131n Amac\u0131 ve \u00d6nemi<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">North Star Ambulatuvar De\u011ferlendirmesi, Duchenne kas distrofisinin y\u00f6netiminde birka\u00e7 \u00f6nemli rol oynar:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hastal\u0131\u011f\u0131n ilerlemesinin izlenmesi:<\/strong> Klinik\u00e7ilere zaman i\u00e7inde fonksiyonel yetenekteki de\u011fi\u015fikliklerin objektif bir \u00f6l\u00e7\u00fcm\u00fcn\u00fc sa\u011flar.<\/li>\n\n\n\n<li><strong>Tedavi etkinli\u011finin de\u011ferlendirilmesi:<\/strong> Kortikosteroidler, ekzon atlama ila\u00e7lar\u0131 veya gen terapisi gibi tedavilerin etkilerini de\u011ferlendirmek amac\u0131yla klinik \u00e7al\u0131\u015fmalarda yayg\u0131n olarak kullan\u0131l\u0131r.<\/li>\n\n\n\n<li><strong>Klinik kararlar\u0131 desteklemek:<\/strong> D\u00fczenli NSAA testleri, m\u00fcdahaleler, fizyoterapi ve adaptif ekipmanlarla ilgili kararlar\u0131n al\u0131nmas\u0131na yard\u0131mc\u0131 olur.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">NSAA y\u00fcr\u00fcme fonksiyonuna odakland\u0131\u011f\u0131ndan, genellikle ba\u011f\u0131ms\u0131z y\u00fcr\u00fcme yetene\u011fini kaybetmeden \u00f6nce, 4-18 ya\u015f aras\u0131ndaki erkek \u00e7ocuklarda kullan\u0131l\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"structure-and-scoring-of-the-nsaa\"><strong>NSAA&#039;n\u0131n Yap\u0131s\u0131 ve Puanlamas\u0131<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">North Star Ambulatuvar De\u011ferlendirmesi, ayakta durma, y\u00fcr\u00fcme, ko\u015fma ve t\u0131rmanma gibi becerileri de\u011ferlendiren 17 fonksiyonel g\u00f6revden olu\u015fur. Her g\u00f6rev 3 puanl\u0131k bir \u00f6l\u00e7ekte puanlan\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2 = G\u00f6revi normal \u015fekilde ger\u00e7ekle\u015ftirir<\/strong><\/li>\n\n\n\n<li><strong>1 = G\u00f6revi de\u011fi\u015fiklik veya yard\u0131mla ger\u00e7ekle\u015ftirir<\/strong><\/li>\n\n\n\n<li><strong>0 = G\u00f6rev ger\u00e7ekle\u015ftirilemiyor<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Toplamda al\u0131nabilecek en y\u00fcksek puan 34 olup tam motor fonksiyonu temsil ederken, daha d\u00fc\u015f\u00fck puanlar daha fazla fonksiyonel bozuklu\u011fa i\u015faret etmektedir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"nsaa-assessed-skills\">NSAA Taraf\u0131ndan De\u011ferlendirilen Beceriler<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Ayakta durmak<\/strong>: D\u0131\u015far\u0131dan destek almadan, m\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre yal\u0131nayak ve hareketsiz durun.<\/li>\n\n\n\n<li><strong>Y\u00fcr\u00fcme<\/strong>: En az 10 ad\u0131m ileriye do\u011fru, topuktan ayak parmaklar\u0131na do\u011fru tutarl\u0131 bir y\u00fcr\u00fcy\u00fc\u015fle y\u00fcr\u00fcy\u00fcn.<\/li>\n\n\n\n<li><strong>Sandalyeden kalkmak<\/strong>: Kollar\u0131n\u0131z\u0131 g\u00f6\u011fs\u00fcn\u00fczde \u00e7aprazlayarak oturun, ard\u0131ndan kollar\u0131n\u0131z\u0131 ay\u0131rmadan sandalyeden kalk\u0131n.<\/li>\n\n\n\n<li><strong>Basama\u011fa \u00e7\u0131kmak (sa\u011f bacak)<\/strong>: En az 15 cm y\u00fcksekli\u011findeki kutu basama\u011fa sa\u011f (veya bask\u0131n) aya\u011f\u0131n\u0131zla \u00e7\u0131k\u0131n.<\/li>\n\n\n\n<li><strong>Basama\u011fa \u00e7\u0131kmak (sol bacak)<\/strong>: En az 15 cm y\u00fcksekli\u011findeki kutu basama\u011fa sol (veya bask\u0131n olmayan) aya\u011f\u0131n\u0131zla \u00e7\u0131k\u0131n ve di\u011fer aya\u011f\u0131n\u0131zla birle\u015ftirin.<\/li>\n\n\n\n<li><strong>Oturmak<\/strong>: Kollar\u0131n\u0131z\u0131 yanlara a\u00e7arak yere d\u00fcz bir \u015fekilde uzan\u0131n ve aya\u011fa kalkmak i\u00e7in yere d\u00f6nmeden veya iki elinizi birden kullanmadan oturma pozisyonuna ge\u00e7in. En y\u00fcksek puan\u0131 almak i\u00e7in tek elinizi kullanman\u0131za izin verilir.<\/li>\n\n\n\n<li><strong>Z\u0131plamak<\/strong>: Her iki aya\u011f\u0131n\u0131z\u0131 birle\u015ftirerek yere bas\u0131n ve m\u00fcmk\u00fcn oldu\u011funca y\u00fckse\u011fe z\u0131play\u0131n, \u00f6ne do\u011fru minimum hareket yap\u0131n.<\/li>\n\n\n\n<li><strong>Ko\u015fmak<\/strong>: Yakla\u015f\u0131k 10 metre boyunca olabildi\u011fince h\u0131zl\u0131 ko\u015fun. En y\u00fcksek puan\u0131 almak i\u00e7in ko\u015farken her iki aya\u011f\u0131n\u0131z\u0131n da yerden y\u00fcksekte olmas\u0131 gerekir.<\/li>\n\n\n\n<li><strong>Sa\u011f ayak \u00fczerinde durmak<\/strong>: M\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre sa\u011f ayak \u00fczerinde durun, kollar\u0131n\u0131z\u0131 a\u015fa\u011f\u0131da tutun.<\/li>\n\n\n\n<li><strong>Sol ayak \u00fczerinde durmak<\/strong>: M\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre sol ayak \u00fczerinde, kollar a\u015fa\u011f\u0131da duracak \u015fekilde durun.<\/li>\n\n\n\n<li><strong>Basamaktan inmek (sa\u011f bacak)<\/strong>: \u00d6ne do\u011fru bak\u0131larak, sa\u011f (veya bask\u0131n) ayakla kutudan (basamaktan) a\u015fa\u011f\u0131 inmek.<\/li>\n\n\n\n<li><strong>Basamaktan inmek (sol bacak)<\/strong>: \u00d6ne do\u011fru bak\u0131larak sol (veya bask\u0131n) ayakla kutudan (basamaktan) a\u015fa\u011f\u0131 di\u011fer aya\u011f\u0131n yan\u0131na inmek.<\/li>\n\n\n\n<li><strong>Topuklar\u0131n \u00fczerinde durmak<\/strong>: \u00c7\u0131plak ayakla topuklar\u0131n\u0131z\u0131n \u00fczerine \u00fc\u00e7 saniye yaslan\u0131n. En y\u00fcksek puan\u0131 almak i\u00e7in, her iki aya\u011f\u0131n\u0131z\u0131 da ayn\u0131 anda, belirgin bir dorsifleksiyon (aya\u011f\u0131 kaval kemi\u011fine do\u011fru kald\u0131rma) kullanarak kald\u0131rmal\u0131s\u0131n\u0131z.<\/li>\n\n\n\n<li><strong>Yerden y\u00fckselmek<\/strong>: S\u0131rt \u00fcst\u00fc uzan\u0131n ve d\u00f6rt noktal\u0131 diz \u00fcst\u00fc veya y\u00fcz\u00fcst\u00fc pozisyona (Gower manevras\u0131) d\u00f6nmeden olabildi\u011fince \u00e7abuk aya\u011fa kalk\u0131n.<\/li>\n\n\n\n<li><strong>Ba\u015f\u0131n kald\u0131r\u0131lmas\u0131<\/strong>: Kollar\u0131n\u0131z\u0131 g\u00f6\u011fs\u00fcn\u00fczde \u00e7aprazlayarak ve ellerinizi omuzlar\u0131n\u0131z\u0131n alt\u0131na koyarak yere d\u00fcz bir \u015fekilde uzan\u0131n. Ard\u0131ndan, kollar\u0131n\u0131z\u0131 kavu\u015fturmu\u015f halde ba\u015f\u0131n\u0131z\u0131 kald\u0131r\u0131n, \u00e7enenizi g\u00f6\u011fs\u00fcn\u00fcze de\u011fdirin.<\/li>\n\n\n\n<li><strong>Sa\u011f bacak \u00fczerinde z\u0131plama<\/strong>: Sa\u011f ayak \u00fczerinde durun ve iki aya\u011f\u0131n\u0131z\u0131n \u00fczerine basmadan tek ayak \u00fczerinde z\u0131play\u0131n.<\/li>\n\n\n\n<li><strong>Sol bacak \u00fczerinde z\u0131plama<\/strong>: Sol ayak \u00fczerinde durun ve her iki aya\u011f\u0131n\u0131z\u0131n \u00fczerine basmadan tek ayak \u00fczerinde z\u0131play\u0131n<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">Testin uygulanmas\u0131 h\u0131zl\u0131d\u0131r (genellikle 10-15 dakika) ve minimum ekipman gerektirir, bu da onu rutin klinik ziyaretleri i\u00e7in pratik hale getirir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"interpreting-nsaa-scores\"><strong>NSAA Puanlar\u0131n\u0131n Yorumlanmas\u0131<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisinde Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirme (NSAA) puanlar\u0131 genellikle \u00f6ng\u00f6r\u00fclebilir bir seyir izleme e\u011filimindedir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Erken \u00e7ocukluk d\u00f6nemi (4-7 ya\u015f):<\/strong> Motor beceriler geli\u015ftik\u00e7e puanlar genellikle artar.<\/li>\n\n\n\n<li><strong>Orta \u00e7ocukluk d\u00f6nemi (7-10 ya\u015f):<\/strong> Skorlar plato yapar ve motor \u00f6\u011frenme ile kas zay\u0131fl\u0131\u011f\u0131 aras\u0131ndaki dengeyi yans\u0131t\u0131r.<\/li>\n\n\n\n<li><strong>Ge\u00e7 \u00e7ocukluk d\u00f6nemi (10 ya\u015f ve \u00fczeri):<\/strong> \u0130lerleyen kas dejenerasyonu belirli yeteneklerin kayb\u0131na yol a\u00e7t\u0131\u011f\u0131ndan puanlar d\u00fc\u015fer.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">NSAA de\u011fi\u015fikliklerinin zaman i\u00e7inde izlenmesi, klinisyenlerin klinik olarak anlaml\u0131 farkl\u0131l\u0131klar\u0131 (CMD&#039;ler) tespit etmelerine yard\u0131mc\u0131 olur; klinik \u00e7al\u0131\u015fmalarda genellikle \u22652 puanl\u0131k bir de\u011fi\u015fiklik anlaml\u0131 kabul edilir. Videoyu \u0130zleyin: <a href=\"https:\/\/www.youtube.com\/watch?v=dgzDd5_fsDY\" target=\"_blank\" rel=\"noopener\">Duchenne Hastal\u0131\u011f\u0131nda Motor Fonksiyonun De\u011ferlendirilmesi<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"use-of-the-nsaa-in-clinical-trials\"><strong>NSAA&#039;n\u0131n Klinik Ara\u015ft\u0131rmalarda Kullan\u0131m\u0131<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">NSAA, bir\u00e7ok Duchenne klinik \u00e7al\u0131\u015fmas\u0131nda birincil veya ikincil bir sonlan\u0131m noktas\u0131d\u0131r. 6 Dakikal\u0131k Y\u00fcr\u00fcme Mesafesi (6DYM) ve zamanl\u0131 fonksiyon testleri (\u00f6rne\u011fin, aya\u011fa kalkma veya merdiven \u00e7\u0131kma s\u00fcresi) gibi di\u011fer sonu\u00e7larla g\u00fc\u00e7l\u00fc bir korelasyon g\u00f6steren, objektif ve tekrarlanabilir bir motor fonksiyon \u00f6l\u00e7\u00fcm\u00fc sa\u011flar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">G\u00fcnl\u00fck ya\u015famla ilgili i\u015flevsel g\u00f6revleri kapsad\u0131\u011f\u0131 i\u00e7in hastalar ve aileler i\u00e7in anlaml\u0131 geli\u015fmeleri yans\u0131t\u0131r ve bu da onu yeni tedavilerin d\u00fczenleyici de\u011ferlendirmesinde olduk\u00e7a de\u011ferli k\u0131lar. Devam\u0131n\u0131 Oku: <a href=\"https:\/\/dmdwarrior.com\/tr\/how-to-participate-in-clinical-trials-for-duchenne\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u00c7ocu\u011fum Duchenne Klinik Denemelerine Nas\u0131l Kat\u0131labilir?<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"limitations-of-the-nsaa\"><strong>NSAA&#039;n\u0131n s\u0131n\u0131rlamalar\u0131<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">North Star Ambulatuvar De\u011ferlendirmesi (NSAA) g\u00fc\u00e7l\u00fc bir de\u011ferlendirme arac\u0131 olmas\u0131na ra\u011fmen baz\u0131 s\u0131n\u0131rlamalar\u0131 vard\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bu sadece ayaktan hastalar i\u00e7in ge\u00e7erlidir; ayaktan y\u00fcr\u00fcyemeyen erkek \u00e7ocuklarda \u00dcst Ekstremite Performans\u0131 (PUL) testi gibi di\u011fer \u00f6l\u00e7eklere ihtiya\u00e7 vard\u0131r.<\/li>\n\n\n\n<li>Puanlama sistemi objektif olmas\u0131na ra\u011fmen de\u011ferlendiriciler aras\u0131nda de\u011fi\u015fkenlik g\u00f6sterebilir ve bu da e\u011fitimli fizyoterapistlere olan ihtiyac\u0131 vurgular.<\/li>\n\n\n\n<li>\u00c7evresel fakt\u00f6rler ve motivasyon s\u0131nav g\u00fcnlerindeki performans\u0131 etkileyebilir.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bunlara ra\u011fmen NSAA, Duchenne kas distrofisinde y\u00fcr\u00fcme fonksiyonunun de\u011ferlendirilmesinde alt\u0131n standart olmaya devam etmektedir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"most-common-question-about-north-star-ambulatory-assessment-nsaa\"><strong>North Star Ambulatuvar De\u011ferlendirmesi (NSAA): Sorular ve Cevaplar<\/strong><\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list\">\n<div id=\"faq-question-1761824999344\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirmesi (NSAA) nedir?<\/h3>\n<div class=\"rank-math-answer\">\n<img loading=\"lazy\" decoding=\"async\" width=\"1080\" height=\"1080\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/North-Star-Ambulatory-Assessment-NSAA.jpg\" class=\"alignright\" alt=\"Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirmesi (NSAA) nedir?\" title=\"\">\n<p>North Star Ambulatuvar De\u011ferlendirmesi (NSAA), Duchenne Musk\u00fcler Distrofisi (DMD) olan y\u00fcr\u00fcyen erkek \u00e7ocuklarda motor becerileri \u00f6l\u00e7mek i\u00e7in tasarlanm\u0131\u015f 17 maddelik fonksiyonel bir \u00f6l\u00e7ektir.<\/p>\n<p>G\u00fcnl\u00fck hareketlilik i\u00e7in gerekli olan ayakta durma, y\u00fcr\u00fcme, ko\u015fma, merdiven \u00e7\u0131kma, z\u0131plama gibi aktiviteleri de\u011ferlendirir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825035673\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Duchenne Musk\u00fcler Distrofi&#039;de NSAA neden kullan\u0131l\u0131r?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>NSAA, DMD&#039;li erkek \u00e7ocuklarda fonksiyonel yetenek ve hastal\u0131k ilerlemesinin nicel bir \u00f6l\u00e7\u00fcm\u00fcn\u00fc sa\u011flad\u0131\u011f\u0131 i\u00e7in kullan\u0131l\u0131r.<\/p>\n<p>Klinik\u00e7iler ve ara\u015ft\u0131rmac\u0131lar bunu \u015fu ama\u00e7larla kullan\u0131r:<\/p>\n<p>\u2022 Zaman i\u00e7inde motor performans\u0131ndaki de\u011fi\u015fiklikleri izlemek i\u00e7in<br \/>\u2022 Yeni tedavilerin veya terapilerin etkinli\u011fini de\u011ferlendirmek<br \/>\u2022 Kortikosteroid kullan\u0131m\u0131n\u0131n ve fizyoterapi m\u00fcdahalelerinin etkisini izlemek<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825143662\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA testini kimler yapt\u0131rabilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>NSAA genellikle n\u00f6rom\u00fcsk\u00fcler bozukluklar konusunda uzmanla\u015fm\u0131\u015f e\u011fitimli fizyoterapistler veya klinisyenler taraf\u0131ndan uygulan\u0131r. Uygun e\u011fitim, puanlaman\u0131n farkl\u0131 de\u011ferlendiriciler ve \u00e7al\u0131\u015fma merkezleri aras\u0131nda tutarl\u0131 ve g\u00fcvenilir olmas\u0131n\u0131 sa\u011flar.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825159756\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA nas\u0131l puanlan\u0131yor?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>17 maddenin her biri \u015fu \u015fekilde puanlan\u0131r:<\/p>\n<p>\u2022 2 puan \u2013 aktiviteyi normal \u015fekilde ger\u00e7ekle\u015ftirme<br \/>\u2022 1 puan \u2013 aktiviteyi telafi veya zorlukla ger\u00e7ekle\u015ftirme<br \/>\u2022 0 puan \u2013 aktiviteyi ger\u00e7ekle\u015ftirememe<\/p>\n<p>Toplamda al\u0131nabilecek en y\u00fcksek puan 34 olup, daha y\u00fcksek puanlar daha iyi motor fonksiyonuna i\u015faret etmektedir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825213163\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA&#039;n\u0131n tamamlanmas\u0131 ne kadar zaman al\u0131r?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>De\u011ferlendirmenin tamamlanmas\u0131, \u00e7ocu\u011fun i\u015fbirli\u011fi d\u00fczeyine ve yorgunlu\u011funa ba\u011fl\u0131 olarak genellikle 10-15 dakika kadar s\u00fcrer.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825239921\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA tam olarak neyi \u00f6l\u00e7\u00fcyor?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>North Star Ambulatuvar De\u011ferlendirmesi (NSAA), kaba motor becerileri ve y\u00fcr\u00fcme fonksiyonunu \u00f6l\u00e7er:<\/p>\n<p>\u2022 Ayakta denge<br \/>\u2022 Yerden kalkma<br \/>\u2022 Y\u00fcr\u00fcme ve ko\u015fma yetene\u011fi<br \/>\u2022 Merdiven \u00e7\u0131kma<br \/>\u2022 Z\u0131plama ve sekme<\/p>\n<p>Bu g\u00f6revler Duchenne Musk\u00fcler Distrofi&#039;nin en \u00e7ok etkiledi\u011fi g\u00fcnl\u00fck motor becerileri yans\u0131tmaktad\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825277811\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA hangi ya\u015flarda kullan\u0131labilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>NSAA genellikle hareket kabiliyetini hala koruyan 4-18 ya\u015f aras\u0131 erkek \u00e7ocuklar i\u00e7in uygundur. Ancak test, motor becerilerin genellikle zirveye ula\u015ft\u0131\u011f\u0131 ve ard\u0131ndan DMD&#039;de kademeli olarak azald\u0131\u011f\u0131 5-12 ya\u015f aras\u0131 en bilgilendirici d\u00f6nemdir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825294335\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA ne s\u0131kl\u0131kla yap\u0131lmal\u0131d\u0131r?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Klinik pratikte ve ara\u015ft\u0131rma \u00e7al\u0131\u015fmalar\u0131nda NSAA, hastal\u0131\u011f\u0131n ilerlemesini ve tedaviye yan\u0131t\u0131 izlemek amac\u0131yla s\u0131kl\u0131kla 6 ila 12 ayda bir yap\u0131l\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825309981\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Duchenne Musk\u00fcler Distrofisi&#039;nde klinik \u00e7al\u0131\u015fmalarda NSAA nas\u0131l kullan\u0131l\u0131r?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirmesi (NSAA), bir\u00e7ok DMD klinik \u00e7al\u0131\u015fmas\u0131nda birincil veya ikincil bir sonu\u00e7 \u00f6l\u00e7\u00fct\u00fcd\u00fcr. Yeni bir ilac\u0131n, gen tedavisinin veya ekzon atlama tedavisinin motor fonksiyonlardaki d\u00fc\u015f\u00fc\u015f\u00fc yava\u015flatmada etkili olup olmad\u0131\u011f\u0131n\u0131 belirlemeye yard\u0131mc\u0131 olur.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825328456\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA&#039;n\u0131n s\u0131n\u0131rlamalar\u0131 nelerdir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>North Star Ambulatuvar De\u011ferlendirmesi de\u011ferli bir ara\u00e7 olmas\u0131na ra\u011fmen baz\u0131 s\u0131n\u0131rlamalar\u0131 vard\u0131r:<\/p>\n<p>\u2022 Sadece ayaktan (y\u00fcr\u00fcyebilen) hastalar i\u00e7in uygundur.<br \/>\u2022 Hastal\u0131\u011f\u0131n ilerlemesinin erken veya ge\u00e7 d\u00f6nemlerinde motor fonksiyonlardaki ince de\u011fi\u015fiklikleri tespit edemeyebilir.<br \/>\u2022 Tutarl\u0131 sonu\u00e7lar i\u00e7in e\u011fitimli de\u011ferlendiricilere ihtiya\u00e7 vard\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825354752\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">DMD&#039;li bir \u00e7ocuk y\u00fcr\u00fcyemez hale geldi\u011finde ne olur?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Y\u00fcr\u00fcme yetene\u011fi kayboldu\u011funda, NSAA art\u0131k ge\u00e7erli de\u011fildir. Klinisyenler daha sonra kol ve \u00fcst v\u00fccut fonksiyonunu izlemek i\u00e7in \u00dcst Ekstremite Performans\u0131 (PUL) de\u011ferlendirmesi gibi alternatif \u00f6l\u00e7ekler kullan\u0131rlar.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825371612\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA DMD&#039;de y\u00fcr\u00fcme kayb\u0131n\u0131 \u00f6ng\u00f6rebilir mi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Evet. Zamanla azalan Kuzey Y\u0131ld\u0131z\u0131 Ambulatuvar De\u011ferlendirme (NSAA) puanlar\u0131n\u0131n, y\u00fcr\u00fcme yetene\u011finin kayb\u0131n\u0131n zamanlamas\u0131yla ili\u015fkili oldu\u011fu g\u00f6sterilmi\u015ftir. \u00d6rne\u011fin, NSAA puan\u0131 18&#039;in alt\u0131nda olan erkek \u00e7ocuklar genellikle \u00f6n\u00fcm\u00fczdeki 2-3 y\u0131l i\u00e7inde y\u00fcr\u00fcme yetene\u011fini kaybetme riski alt\u0131ndad\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825393528\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA g\u00fcvenilir ve ge\u00e7erli mi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Evet. NSAA klinik olarak do\u011frulanm\u0131\u015f olup, m\u00fckemmel bir de\u011ferlendiriciler aras\u0131 ve test-tekrar test g\u00fcvenilirli\u011fi g\u00f6stermektedir. Duchenne Musk\u00fcler Distrofisi i\u00e7in hem klinik bak\u0131mda hem de uluslararas\u0131 ara\u015ft\u0131rma \u00e7al\u0131\u015fmalar\u0131nda yayg\u0131n olarak kabul g\u00f6rmektedir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825415116\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Aileler \u00e7ocuklar\u0131n\u0131 NSAA testine nas\u0131l haz\u0131rlayabilirler?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Ebeveynler \u015fu \u015fekilde yard\u0131mc\u0131 olabilir:<\/p>\n<p>\u2022 \u00c7ocu\u011fun rahat k\u0131yafetler ve ayakkab\u0131lar giymesini sa\u011flamak<br \/>\u2022 Yorgunlu\u011fu \u00f6nlemek i\u00e7in \u00e7ocu\u011fun testten \u00f6nce dinlenmesini te\u015fvik etmek<br \/>\u2022 \u00c7ocu\u011fun her g\u00f6revi g\u00fcvenle yerine getirmesine yard\u0131mc\u0131 olmak i\u00e7in g\u00fcvence sa\u011flamak<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1761825442589\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">NSAA formu veya puanlama tablosu nerede bulunabilir?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Resmi NSAA formu ve detayl\u0131 puanlama y\u00f6nergelerine \u015fu adresten ula\u015fabilirsiniz:<\/p>\n<p>\u2022 N\u00f6rom\u00fcsk\u00fcler Bozukluklar i\u00e7in Kuzey Y\u0131ld\u0131z\u0131 Klinik A\u011f\u0131 (NSCN)<br \/>\u2022 N\u00f6rom\u00fcsk\u00fcler dergilerde yay\u0131nlanm\u0131\u015f klinik \u00e7al\u0131\u015fmalar<br \/>\u2022 Yetkili klinik ara\u015ft\u0131rma dok\u00fcmantasyonu<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\" id=\"conclusion\"><strong>Sonu\u00e7<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>North Star Ambulatuvar De\u011ferlendirmesi (NSAA), Duchenne kas distrofisi olan erkek \u00e7ocuklarda motor fonksiyonun de\u011ferlendirilmesinde temel bir ara\u00e7t\u0131r.<\/strong> Basitli\u011fi, g\u00fcvenilirli\u011fi ve hassasiyeti, onu hem klinik y\u00f6netim hem de ara\u015ft\u0131rma \u00e7al\u0131\u015fmalar\u0131 i\u00e7in vazge\u00e7ilmez k\u0131lmaktad\u0131r. NSAA, motor becerilerdeki de\u011fi\u015fiklikleri sistematik olarak izleyerek, klinisyenlerin ve ara\u015ft\u0131rmac\u0131lar\u0131n hastal\u0131k ilerlemesini daha iyi anlamalar\u0131na ve yeni tedavilerin ger\u00e7ek d\u00fcnyadaki etkisini \u00f6l\u00e7melerine olanak tan\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"key-takeaways\"><strong>\u00d6nemli \u00c7\u0131kar\u0131mlar<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NSAA, DMD&#039;de ambulatuvar motor fonksiyonunu 17 g\u00f6rev arac\u0131l\u0131\u011f\u0131yla \u00f6l\u00e7er.<\/li>\n\n\n\n<li>Puanlar 0 ile 34 aras\u0131nda de\u011fi\u015fmektedir ve daha y\u00fcksek puanlar daha iyi i\u015flevi g\u00f6stermektedir.<\/li>\n\n\n\n<li>Tedavi etkilerini izlemek i\u00e7in klinik \u00e7al\u0131\u015fmalarda yayg\u0131n olarak kullan\u0131l\u0131r.<\/li>\n\n\n\n<li>D\u00fczenli NSAA testi, ki\u015fiselle\u015ftirilmi\u015f bak\u0131m\u0131 ve erken m\u00fcdahaleyi destekler.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Devam\u0131n\u0131 oku<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" data-type=\"page\" data-id=\"4611\">Duchenne \u0130\u00e7in Klinik Ara\u015ft\u0131rmalar (T\u00fcm Ara\u015ft\u0131rmalar\u0131n Listesi)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The North Star Ambulatory Assessment (NSAA) is a standardized, clinician-administered tool designed to evaluate motor performance in ambulant boys with Duchenne muscular dystrophy (DMD). Developed by the North Star Clinical Network for Neuromuscular Diseases, it provides a reliable way to track disease progression and assess treatment outcomes in both clinical practice and research settings. Duchenne [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4960,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[449],"class_list":["post-4959","post","type-post","status-publish","format-standard","has-post-thumbnail","category-dmd","tag-nsaa"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=4959"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4959\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/4960"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=4959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=4959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=4959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}